INDEMNITY AGREEMENTIndemnity Agreement • September 9th, 2024 • 180 Life Sciences Corp. • Pharmaceutical preparations • Delaware
THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of September 3, 2024, by and between 180 LIFE SCIENCES CORP., a Delaware corporation (the “Company”), and Sir Marc Feldmann (“Indemnitee”).
SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • September 9th, 2024 • 180 Life Sciences Corp. • Pharmaceutical preparations • California
This Separation and Release Agreement (this “Agreement and Release” or “Agreement”) dated August 30, 2024, is made by and between Marc Feldmann, an individual (“Feldmann”) and Cannbiorex Pharma Ltd., a U.K. corporation (“CBR”), a wholly-owned subsidiary of 180 Life Sciences Corp. (“180 LS”, and 180 LS, together with CBR, the “Company”), and the Company (collectively referred to as the “Parties” or individually referred to as a “Party”).
